Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2021

Jun 2, 2021

29821_dirs_2021-06-02_5baacd9c-2243-499c-b116-6be201ec7bf3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-06-01

Reporting Person: Butcher Arthur C (EVP&Pres, Asia Pacific)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-01 Common Stock M 1762.0000 $0.0000 Acquired 31160.0000 Direct
2021-06-01 Common Stock F 696.0000 $42.9300 Disposed 30464.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-06-01 Deferred Stock Units $ M 1762.0000 Disposed 2021-06-01 Common Stock (1762.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2553.0000 Indirect

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.

F3: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant.